Vycor Medical Inc

Vycor Medical Inc

Vycor Medical Inc (OTC: VYCO) develops and commercializes medical devices for neurosurgery. The company's lead product is the ViewSite Brain Access System, a tubular retractor designed to provide surgeons with a clear corridor to brain lesions while minimizing tissue disruption (public record). Vycor also markets the NovaVision line of vaginal elevators for gynecologic surgeries, showing a broader surgical focus. The company's strategy centers on direct sales and partnerships with hospitals and surgical centers in the US. It holds patents protecting its technology. Vycor's device has been used in thousands of neurosurgical procedures, with clinical studies indicating reduced length of stay and lower complication rates (per SEC filings). Revenue is generated from product sales, not from investing or capital management. Vycor Medical is a publicly traded company with a microcap market cap, not a family office or investment firm. Its team includes executives with medical device and surgical experience. No additional offices or philanthropic vehicles have been disclosed. The company reported revenue of $2.1 million in 2024 (per financial filings, FY2024). The firm's structural differentiator is its focus on a narrow surgical niche — brain access — and its ability to compete against larger rivals like Medtronic and Integra LifeSciences. Vycor's regulatory posture includes FDA clearance for its ViewSite system, a meaningful barrier for new entrants. The company is publicly traded, so its governance is subject to SEC reporting requirements rather than private family office rules.